Abstract
Novel tricyclic cis-fused pyrrolidines were synthesized via a key tandem aza-Cope rearrangement–Mannich cyclization, enabling efficient construction of the core scaffold. The compounds were evaluated for antiviral activity and cytotoxicity against herpes simplex virus (HSV) and cytomegalovirus (CMV). Two compounds showed moderate anti-CMV activity (IC50 ≈ 23 µg/mL) with selectivity indices around 5, highlighting the promise of this scaffold for further optimization.
Keywords
cytomegalovirus
herpes simplex virus
nitrogen heterocycles
tandem aza-Cope/Mannich
tricyclic pyrrolidine